clou219 Posted - 3 days ago

$ALIM very quiet board?

epsguid Posted - 4 days ago

$ALIM reported a loss of $0.12, consensus was ($0.04) via @eWhispers #epsmiss http://eps.sh/d/alim

Thestocktraderhubzee Posted - 4 days ago

$ALIM Alimera Sciences Q1 EPS $(0.12) Misses $(0.06) Estimate, Sales $23.01M Beat $22.25M Estimate

Stock_Titan Posted - 4 days ago

$ALIM Alimera Sciences Reports First Quarter 2024 Results https://www.stocktitan.net/news/ALIM/alimera-sciences-reports-first-quarter-2024-8nr4m8mqu6td.html

Stock_Titan Posted - 1 week ago

$ALIM Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress Conferences https://www.stocktitan.net/news/ALIM/alimera-announces-scientific-data-highlighting-yutiq-r-to-be-qvmsosnu48gu.html

Stock_Titan Posted - 04/30/24

$ALIM Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update https://www.stocktitan.net/news/ALIM/alimera-sciences-to-report-first-quarter-2024-financial-results-on-ijc0f6kh6f3i.html

Doozio Posted - 1 month ago

$ALIM when 🧠⏰?

Stock_Titan Posted - 03/20/24

$ALIM Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/ALIM/alimera-sciences-reports-inducement-grants-under-nasdaq-listing-rule-0p6qj9vbe6lp.html

Stock_Titan Posted - 03/19/24

$ALIM Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network https://www.stocktitan.net/news/ALIM/alimera-announces-first-patient-randomized-in-radiation-retinopathy-llcxuvx7zstp.html

Fullratio Posted - 2 months ago

$ALIM total liabilities has soared by 69% YoY: https://fullratio.com/stocks/nasdaq-alim/alimera-sciences

epsguid Posted - 2 months ago

$ALIM reported a loss of $0.07, consensus was $0.02 via @eWhispers #epsmiss http://eps.sh/d/alim

DonCorleone77 Posted - 2 months ago

$ALIM Alimera Sciences reports Q4 EPS (7c) vs (54c) last year Reports Q4 revenue $26.3M, consensus $24.34M. "Our outstanding fourth quarter and full year 2023 net revenue of $26.3 million and $80.8 million, respectively, mark major achievements for Alimera and are a testament to the realized vision and strong execution of our entire team in only our second full quarter marketing both ILUVIEN and YUTIQ," said Rick Eiswirth, Alimera's President and Chief Executive Officer. "We are proud to have achieved positive Adjusted EBITDA during the fourth quarter of 2023, while maintaining a consistent net loss compared to the fourth quarter of 2022, despite facing greater interest and amortization expenses following the YUTIQ acquisition."

Stock_Titan Posted - 2 months ago

$ALIM Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results https://www.stocktitan.net/news/ALIM/alimera-sciences-reports-fourth-quarter-and-full-year-2023-hag4650unjdg.html

Ninja_Tradez Posted - 02/29/24

📢 $ALIM - Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update https://newsfilter.io/a/2cfa0595882c79da2965ac6d1d5fc7c4

Stock_Titan Posted - 02/29/24

$ALIM Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update https://www.stocktitan.net/news/ALIM/alimera-sciences-to-report-fourth-quarter-and-full-year-2023-pfuepq6fknpk.html

TickerDD_com Posted - 02/21/24

From 2/16/2024, looking back across 22 Month-Ends for ALIM, Percentage Change of Average Monthly Price had Equal (50%) while Percentage Change of Average Monthly Volume had All Positives (100%) $ALIM #ALIM #ALIMStock #TickerDD #ALIMPrice https://www.youtube.com/watch?v=ZU1UAQvqlsM

Stock_Titan Posted - 3 months ago

$ALIM The UK National Institute for Health and Care Excellence (NICE) Issues Final Draft Guidance to Provide Patients with a Natural Lens (Phakic Eye) Being Treated for Chronic Diabetic Macular Edema Access to ILUVIEN® https://www.stocktitan.net/news/ALIM/the-uk-national-institute-for-health-and-care-excellence-nice-issues-3mwgqlmtve28.html

VirmoMopire Posted - 01/30/24

$ALIM Keep an eye on this one. Could be something brewing. 🔍

tickeron Posted - 01/21/24

This is amazing! What do you think? $ALIM Stochastic Oscillator left the oversold zone. View odds of downtrend. https://srnk.us/go/4974732

cctranscripts Posted - 4 months ago

Alimera Sciences's President of Int'l Operations just disposed of 2,938 shares https://www.conferencecalltranscripts.org/summary/?id=12860492 $ALIM

JimAHernandez Posted - 4 months ago

$NFLX $ALIM Analyst price target for next week- top-gains-stock-chat-today.blogspot.com/2024/01/top-gains-stock-chat-today.html

tickeron Posted - 4 months ago

$ALIM enters bullish trend https://srnk.us/go/4961770

tickeron Posted - 4 months ago

$ALIM enters bullish trend https://srnk.us/go/4960870

Last10K Posted - 4 months ago

$ALIM just filed with the SEC a Event for Officers and a Financial Exhibit https://last10k.com/sec-filings/ALIM/0001104659-24-001326.htm?utm_source=stocktwits&utm_medium=forum&utm_campaign=8K&utm_term=ALIM

risenhoover Posted - 4 months ago

Also, if you are new to $ALIM here's a background article on Finpedia for you https://finpedia.co/bin/Almira%20Sciences/

risenhoover Posted - 4 months ago

$ALIM / Alimera Sciences files form 8-K - UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 Date of Report (Date of earliest event reported): December 28, 2023 ALIMERA SCIENCE https://fintel.io/doc/sec-alimera-sciences-inc-1267602-8k-2024-january-04-19726-4298?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=filing

tickeron Posted - 4 months ago

$ALIM enters bullish trend https://srnk.us/go/4959945

Stock_Titan Posted - 4 months ago

$ALIM Alimera Completes Recruitment for the Synchronicity Study https://www.stocktitan.net/news/ALIM/alimera-completes-recruitment-for-the-synchronicity-nnz6qefk65jl.html

tickeron Posted - 4 months ago

$ALIM enters bullish trend https://srnk.us/go/4959033

Stock_Titan Posted - 4 months ago

$ALIM Alimera Sciences Names Elliot Maltz as Chief Financial Officer and Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) https://www.stocktitan.net/news/ALIM/alimera-sciences-names-elliot-maltz-as-chief-financial-officer-and-nczjz9qc8ky8.html